Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results

Rhea-AI Summary

Global Cord Blood Corporation (NYSE: CO), a leader in cord blood banking in China, will release its financial results for Q3 and the first nine months of fiscal 2022 on February 28, 2022, post U.S. market close. A conference call to discuss the results is scheduled for March 1, 2022, at 8:00 a.m. ET, accessible via the Company’s IR website. Supplemental financial information will be available after the results announcement. The company specializes in cord blood collection, testing, processing, and storage services.

HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its financial results for the third quarter and first nine months of fiscal 2022 on Monday, February 28, 2022, after the U.S. market close. 

The Company will host a conference call at 8:00 a.m. ET on Tuesday, March 1, 2022 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question-and-answer session. Interested parties can access the audio webcast through the Company's IR website at http://ir.globalcordbloodcorp.com. A replay of the webcast will be accessible two hours after the conference call and available for 7 days at the same URL as above. Listeners can also access the call by dialing 1-855-824-5644 or 1-646-722-4977, for US callers, or +852-3027-6500, for Hong Kong callers, access code: 61137296#.

Please dial in ten minutes prior to the conference call to ensure proper connection, and be prepared to provide contact details to the operator.

Supplemental financial information referenced in the conference call and the third quarter fiscal 2022 earnings press release will be available at http://www.globalcordbloodcorp.com, in the section titled "Investor Center/Press Release", after 4:16 p.m. ET on Monday, February 28, 2022, and in the Company's Report on Form 6-K for the month of February 2022, available on the Securities and Exchange Commission's website at www.sec.gov.  

About Global Cord Blood Corporation

Global Cord Blood Corporation is an umbilical cord blood banking operator serving multiple regions in China. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at:
http://www.globalcordbloodcorp.com.  

View original content:https://www.prnewswire.com/news-releases/global-cord-blood-corporation-to-report-third-quarter-and-first-nine-months-fiscal-2022-financial-results-301488324.html

SOURCE Global Cord Blood Corporation

FAQ

When will Global Cord Blood Corporation release its Q3 fiscal 2022 financial results?

Global Cord Blood Corporation will release its Q3 fiscal 2022 financial results on February 28, 2022, after U.S. market close.

What is the date and time of the conference call for Global Cord Blood's financial results?

The conference call to discuss the financial results is scheduled for March 1, 2022, at 8:00 a.m. ET.

How can I access the financial results webcast for Global Cord Blood Corporation?

The financial results webcast can be accessed through the Company’s IR website at http://ir.globalcordbloodcorp.com.

Will there be supplemental financial information available for Global Cord Blood Corporation?

Yes, supplemental financial information will be available after the results announcement on February 28, 2022.